BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/15/2023 4:42:25 AM | Browse: 124 | Download: 135
 |
Received |
|
2023-02-10 21:57 |
|
Peer-Review Started |
|
2023-02-10 21:59 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2023-03-15 02:58 |
|
Revised |
|
2023-04-19 01:27 |
|
Second Decision |
|
2023-06-14 02:59 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2023-06-14 09:37 |
|
Articles in Press |
|
2023-06-14 09:37 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2023-09-11 10:15 |
|
Publish the Manuscript Online |
|
2023-09-15 04:42 |
| ISSN |
2220-3230 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Transplantation |
| Manuscript Type |
Minireviews |
| Article Title |
Sodium-glucose cotransporter-2 inhibitor use in kidney transplant recipients
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Pavithra Ramakrishnan, Neetika Garg, Samantha Pabich, Didier A Mandelbrot and Kurtis J Swanson |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Kurtis J Swanson, MD, Assistant Professor, Department of Medicine, University of Wisconsin School of Medicine and Public Health, Highland Ave Madison, Madison, WI 53705, United States. kswanson@medicine.wisc.edu |
| Key Words |
Sodium glucose cotransporter-2; Sodium glucose cotransporter-2 inhibitor; Kidney transplantation; Diabetes; Post-transplant diabetes mellitus; New onset diabetes after transplant |
| Core Tip |
Multiple large trials have demonstrated sodium-glucose cotransporter-2 inhibitors (SGLT2i) associated kidney and cardiovascular benefits for chronic kidney disease patients with diabetes. Important considerations are critical to determine safety and efficacy of these medications after kidney transplantation. While evidence is limited, SGLT2i appear to be both safe and effective short-term. More robust research is needed to determine the long-term impacts of their use in kidney transplant recipients. Appropriate patient selection and monitoring are vital to clinical use and future research efforts of SGLT2i in kidney transplantation. |
| Publish Date |
2023-09-15 04:42 |
| Citation |
Ramakrishnan P, Garg N, Pabich S, Mandelbrot DA, Swanson KJ. Sodium-glucose cotransporter-2 inhibitor use in kidney transplant recipients. World J Transplant 2023; 13(5): 239-249 |
| URL |
https://www.wjgnet.com/2220-3230/full/v13/i5/239.htm |
| DOI |
https://dx.doi.org/10.5500/wjt.v13.i5.239 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
